NCT05520723 2025-12-04
PRIMED
MedSIR
Phase 2 Completed
Clinical Trials
3 trialsInterventional × Triple Negative Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all
NCT04584112 2023-03-15
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Hoffmann-La Roche
Phase 1 Completed
NCT01378533 2011-12-28
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
ChineseAMS
Phase 3 Unknown